Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-11-24 Exercise |
2023-11-28 4:05 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
59,649 | $1000 | 4,612,951 (Indirect) |
View |
2023-11-24 Exercise |
2023-11-28 4:05 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
4,584,571 | $0 | 4,612,951 (Indirect) |
View |
2023-11-13 Option Award(A) |
2023-11-15 9:10 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
13,269 | $1000 | 31,269 (Indirect) |
View |
2023-11-10 Option Award |
2023-11-14 7:00 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
44,230 | $0 | 99,499 (Indirect) |
View |
2023-11-13 Option Award |
2023-11-14 7:00 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
13,269 | $1000 | 99,499 (Indirect) |
View |
2023-11-13 Exercise |
2023-11-14 7:00 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
13,269 | $0 | 99,499 (Indirect) |
View |
2023-10-23 Option Award |
2023-10-24 5:30 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
16,269 | $1000 | 18,000 (Indirect) |
View |
2023-10-23 Exercise |
2023-10-24 5:30 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
16,269 | $0 | 18,000 (Indirect) |
View |
Ownership |
2023-10-10 4:05 pm |
N/A N/A |
SAB Biotherapeutics Inc. | SABS | Moin Andrew Director |
0 | $0 | 2,805,366 (Indirect) |
View |